Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
Go back to Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94| (NYSE: CLDI) | Delayed: 1.60 +0.06 (3.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.54 | 52 Week High | $ | |||
| Open | $1.50 | 52 Week Low | $ | |||
| Day High | $1.63 | P/E | N/A | |||
| Day Low | $1.50 | EPS | $ | |||
| Volume | 120,735 | |||||

